by Ket Patel | Aug 3, 2024 | Depression
Wrist-based activity sensors worn by individuals with depression and those without over the course of two weeks provided evidence for the relationship between daily sunlight exposure and physical activity, according to a study published September 25, 2024, in the...
by Ket Patel | Jul 29, 2024 | Latest News
• The Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency today issued a negative opinion on the marketing authorisation application of Eisai for lecanemab for the treatment of early Alzheimer’s disease. • Lecanemab has already been...
by Ket Patel | Jul 22, 2024 | All Videos For Neurology, All Videos For Psychiatry, CME, Epilepsy, Home video
This roundtable discussion was supported by Neuraxpharm MODERATOR: PROF. ALEXIS ARZIMANOGLOU Coordinator European Reference Network on Rare and Complex Epilepsies ERN EpiCARE Hospital San Juan De Dios, Barcelona, Spain SPEAKER 1: PROF. LIEVEN LAGAE Head of Paediatric...
by Ket Patel | Jul 15, 2024 | Schizophrenia
Rehearsing alternative outcomes of discarding through imagery rescripting shows promise as a treatment strategy for people who hoard, a study by UNSW psychology researchers has shown. Hoarding disorder is a highly debilitating condition that worsens with age. People...
by Ket Patel | Jul 11, 2024 | Home video, Psychiatry
This webinar was supported by Neuraxpharm In this webinar, our panel of expert speakers discussed critical considerations of first antidepressant treatment failure and the importance of antidepressant metabolism. The international panel shared the nuances of...
